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The lipid transfer activity of phosphatidylinositol transfer protein
is sufficient to account for enhanced phospholipase C activity in
turkey erythrocyte ghosts
Richard A. Currie, Bryan M.G. MacLeod and C. Peter Downes
Background: The minor membrane phospholipid phosphatidylinositol
4,5-bisphosphate (PIP2) has been implicated in the control of a number of cellular
processes. Efficient synthesis of this lipid from phosphatidylinositol has been
proposed to require the presence of a phosphatidylinositol/phosphatidylcholine
transfer protein (PITP), which transfers phosphatidylinositol and
phosphatidylcholine between membranes, but the mechanism by which PITP
exerts its effects is currently unknown. The simplest hypothesis is that PITP
replenishes agonist-sensitive pools of inositol lipids by transferring
phosphatidylinositol from its site of synthesis to sites of consumption. Recent
cellular studies, however, led to the proposal that PITP may play a more active
role as a co-factor which stimulates the activity of phosphoinositide kinases and
phospholipase C (PLC) by presenting protein-bound lipid substrates to these
enzymes. We have exploited turkey erythrocyte membranes as a model system in
which it has proved possible to distinguish between the above hypotheses of
PITP function.
Results: In turkey erythrocyte ghosts, agonist-stimulated PIP2 hydrolysis is
initially rapid, but it declines and reaches a plateau when ~15% of the
phosphatidylinositol has been consumed. PITP did not affect the initial rate of
PIP2 hydrolysis, but greatly prolonged the linear phase of PLC activity until at
least 70% of phosphatidylinositol was consumed. PITP did not enhance the
initial rate of phosphatidylinositol 4-kinase activity but did increase the
unstimulated steady-state levels of both phosphatidylinositol 4-phosphate and
PIP2 by a catalytic mechanism, because the amount of polyphosphoinositides
synthesized greatly exceeded the molar amount of PITP in the assay.
Furthermore, when polyphosphoinositide synthesis was allowed to proceed in
the presence of exogenous PITP, after washing ghosts to remove PITP before
activation of PLC, enhanced inositol phosphate production was observed,
whether or not PITP was present in the subsequent PLC assay.
Conclusions: PITP acts by catalytically transferring phosphatidylinositol down a
chemical gradient which is created as a result of the depletion of
phosphatidylinositol at its site of use by the concerted actions of the
phosphoinositide kinases and PLC. PITP is therefore not a co-factor for the
phosphoinositide-metabolizing enzymes present in turkey erythrocyte ghosts.
Background
The minor membrane phospholipid phosphatidylinositol
4,5-bisphosphate (PIP2) has been implicated in a variety
of cellular processes. Hydrolysis of PIP2 by members of
the receptor-activated, phosphoinositide-specific phos-
pholipase C (PLC) family is now recognized as a ubiqui-
tous signalling mechanism that generates two second
messengers: inositol 1,4,5-trisphosphate (IP3), which raises
intracellular calcium levels, and diacylglycerol (DAG),
which activates some protein kinase C isoforms [1,2].
Growth factor-regulated phosphoinositide 3-kinases use
PIP2 as the principal in vivo substrate for the generation of
the putative second messenger phosphatidylinositol 3,4,5-
trisphosphate (PIP3) [3,4]. PIP2 has been shown to be nec-
essary for priming of Ca2+-dependent secretion [5] and to
be a co-factor for phospholipase D [6,7]. Also, polyphos-
phoinositides have been shown to bind to, and modulate,
the activities of a number of actin-binding proteins in
vitro, and so may be involved in the regulation of actin
polymerization ([8–11] and see [12] for review).
The basal level of PIP2 is maintained at a steady state by
two substrate cycles: firstly, the phosphatidylinositol (PI)
↔ phosphatidylinositol 4-phosphate (PI4P) substrate
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cycle is catalyzed by PI 4-kinase and PI4P 4-phosphatase;
and then the PI4P ↔ PIP2 substrate cycle is catalyzed by
PI4P 5-kinase and PIP2 5-phosphatase [13]. Activation of
PLC by agonists has been calculated to be able rapidly to
metabolize all cellular PIP2. PI is synthesized in the endo-
plasmic reticulum, but these substrate cycles are thought
to occur predominantly in the plasma membrane or other
sites of utilization of PIP2 [13]. Therefore, there must be a
mechanism for the transport of PI from its site of synthesis
to its sites of use by PI kinases in the cell. 
PI/phosphatidylcholine transfer protein (PITP) is ubiqui-
tously expressed in eukaryotic cells and can transfer both
PI and phosphatidylcholine between membranes [14].
PITP seems to be required for the reconstitution, in per-
meabilized or broken cell preparations, of cellular
processes that require PIP2 synthesis, including sustained
activation of PLCb and g isoforms and the ATP-depen-
dent priming of secretion [15–17]. PITP also reconstituted
secretory vesicle formation from the trans-Golgi network
in a cell-free assay [18], although a requirement for PIP2 in
this process has yet to be determined. PITP was originally
proposed to transfer PI from its site of synthesis to its site
of use by PLC (see, for example, [19]). Recently,
however, an analysis of the kinetics of guanosine 5′-(g-
thio)-triphosphate (GTPgS)-stimulated inositol phosphate
production in cytosol-depleted permeabilized HL-60 cells
that had been reconstituted with PITP led to the proposal
that PITP may control the rate of inositol phosphate pro-
duction by acting as a ‘co-factor’ for phosphoinositide-
metabolizing enzymes, and thereby control the rate of
PIP2 synthesis [20]. More specifically, this model pro-
posed that it is the limited pool of PI bound to the PITP,
rather than the PI resident in the plasma membrane, that
is the preferred substrate for the phosphoinositide-metab-
olizing enzymes.
Turkey erythrocyte ghosts are a well characterized and
robust model membrane system and have proved useful
for the analysis of the kinetics of receptor and G-protein-
regulated PLCbs. The regulation of the PLCb isoform in
turkey erythrocytes is essentially identical to the regula-
tion of PLCbs in mammalian cells, because turkey ery-
throcytes contain the avian homologues of a P2y
purinergic receptor [21], Ga11 [22] and PLCb [23]. In
addition, as has been shown for mammalian cells [24], a
wortmannin-sensitive PI 4-kinase is responsible for main-
taining the agonist-sensitive pool of polyphosphoinosi-
tides in turkey erythrocytes (R.A.C. and C.P.D.,
unpublished observations). We have therefore investi-
gated the effect of PITP on phosphoinositide metabolism
in turkey erythrocyte ghosts. Our data support a model
whereby the loss of polyphosphoinositides by the con-
certed actions of PLC and the phosphoinositide kinases
creates a PI chemical gradient between intracellular mem-
branes which acts as the driving force for the net transfer
of PI by the PITP, and do not require a more complex co-
factor mechanism for the action of PITP to be invoked.
Results and discussion
PITP prolongs but does not affect the initial rate of GTPgS-
stimulated PLC activity in turkey erythrocyte ghosts
PITP was purified ~260-fold from bovine brain by a modi-
fication of the method of Helmkamp et al. [25], as
described in the Materials and methods. The PITP prepa-
ration was devoid of PLC and PI kinase activities; a 35 kDa
band, detected with anti-PITP antisera on western blots,
comprised at least 30% of the protein as assessed by silver
staining (data not shown). Preliminary experiments showed
that the effect of PITP on increasing the steady-state level
of PI4P was concentration-dependent. All the experiments
described below used a maximally effective concentration
of PITP, which was equivalent to ~10% of the PITP con-
centration in turkey erythrocyte cytosol, as determined by
PITP activity measurements (data not shown).
We tested the effect of PITP on ATP and GTPgS-stimu-
lated PLC activity in turkey erythrocyte ghosts by moni-
toring the release of radiolabelled inositol phosphates
from prelabelled endogenous inositol phospholipids. As
was shown previously for turkey erythrocyte ghosts [26],
the rate of inositol phosphate production declined rapidly
and ceased when only ~15% of the [3H]-PI had been con-
verted into inositol phosphates (Fig. 1b). However, Figure
1a,b show that, if ghosts were preincubated with PITP to
allow penetration of the transfer protein before stimula-
tion with ATP and GTPgS, there was a dramatic increase
in the amount of PI that could be converted into inositol
phosphates. After 120 minutes (the longest time mea-
sured), ~70% of the PI had been used (Fig. 1b), and inosi-
tol phosphate accumulation was still proceeding at close to
its initial rate (data not shown). However, a significant
divergence in the rate of PLC in the presence of PITP
was not detected until at least 4 minutes after initiating
the reaction (Fig. 1a). Therefore, the presence of the
PITP allows the utilization of PI from sites that are not
immediately available to the phosphoinositide kinases and
PLC, presumably as a result of the lipid transfer activity of
the PITP. Also, as PITP does not enhance the initial rate
of PLC, it cannot act as a co-factor for this enzyme in
turkey erythrocytes.
PITP enhances basal levels of polyphosphoinositides in
turkey erythrocyte ghosts but does not affect the initial
rate of PI 4-kinase
The PI in turkey erythrocyte ghosts can be labelled to
high specific radioactivity by the in vitro labelling method
used in this study [27]. Ghosts that were labelled with
[3H]-inositol solely in PI were incubated with ATP in the
absence of guanine nucleotides, so that ghost endogenous
PI was converted into polyphosphoinositides without
hydrolysis to inositol phosphates. The presence of PITP
186 Current Biology, Vol 7 No 3
in these lipid kinase assays caused the conversion of addi-
tional PI into polyphosphoinositides but did not affect the
initial rate of conversion of PI to PIP (Fig. 1c,d). PI4P
attained a new, higher steady-state level and PIP2 levels
were also increased (Fig. 1d) but did not attain a steady
state even after 2 hours of incubation with ATP. Increas-
ing the concentration of PITP from 10% to 50% of that
estimated to be present in turkey erythrocyte cytosol had
no additional effect. Thus, the effects of PITP are not
limited to turkey erythrocyte ghosts in which PLC has
been activated. PITP also causes the transfer of PI to the
endogenous phosphoinositide kinases under basal condi-
tions, without affecting the activity of the PI 4-kinase;
PITP therefore cannot be a co-factor for this enzyme.
The effect of PITP is catalytic
Although the data presented above demonstrate unequivo-
cally that PITP cannot be a co-factor that activates PI 4-
kinase or PLC, as envisaged by Cunningham et al. [20],
they do not exclude the possibility that PI and the
polyphosphoinositides produced from it remain bound to
the PITP [28] during their metabolism. If this were the
case, then because PITP has a single PI-binding site [14],
there should be a strict stoichiometry of not greater than
one between the molar amount of polyphosphoinositides
synthesized in the presence of PITP and the amount of
PITP itself in the assay, provided that the newly synthe-
sized lipid is not metabolized by activated PLC. We mea-
sured the PI mass in ghosts that had been incubated with
Figure 1
The effect of PITP on the initial rate of PLC
and PI 4-kinase. Well-washed turkey
erythrocyte ghosts labelled with [3H]-inositol
for (a,b) PLC assays or (c,d) PI 4-kinase
assays were preincubated with PITP for 5 min
at 37°C prior to stimulation with 5 mM ATP
and (a,b) 100 mM GTPgS or (c,d) 5 mM ATP
for the times indicated, and then processed
for determination of [3H]-inositol-labelled
inositol phosphate and phosphoinositides, as
described in Materials and methods; the
histograms in (b,d) summarise the data from
120 min incubation. Data are means of
duplicate determinations; each assay was
repeated three times, with less than 5%



















































































ATP in the presence or absence of 1 nmol of PITP for
2 hours. As shown in Table 1, the presence of 1 nmol PITP
caused the conversion of an additional 3 nmol of PI to
polyphosphoinositides, when compared with conversion in
the absence of PITP. This establishes that polyphospho-
inositides, which are responsible for the enhanced PLC
activity upon subsequent stimulation by GTPgS, cannot
all remain bound to PITP.
Continued presence of PITP is not necessary for enhanced
GTPgS-stimulated inositol phosphate production
Our results suggest that, if PITP is present during the
polyphosphoinositide synthesis phase of the assay, the
additional PLC substrate levels should lead to enhanced
PLC activity if GTPgS is added after removal of PITP by
washing the ghosts. Ghosts labelled with [3H]-inositol
were incubated for 2 hours with ATP in the presence or
absence of PITP, and then the ghosts were collected by
centrifugation and washed extensively in lysis buffer. The
washed ghosts contained no detectable PITP immunore-
activity and > 99% of the [3H]-inositol-labelled lipids,
whereas the first centrifugation supernatants did contain
PITP immunoreactivity and had very little labelled lipid
(data not shown). Ghosts incubated with PITP during the
labelling had double the PIP2 levels, and subsequent
GTPgS-stimulated inositol phosphate production was also
initially doubled, as compared with ghosts that were not
treated with PITP, irrespective of the inclusion of PITP
in the actual PLC assay (Fig. 2). Therefore, PLC appears
to act under first-order conditions on lipid that is present
in the ghost membranes, and enhanced PLC activity is
independent of the presence of PITP.
A model for the action of PITP
Turkey erythrocyte ghosts have proved to be a valuable
model for studies of the mode of action of PITP, because
manipulation of the assay conditions allows the endoge-
nous PI kinase and PLC activities to be analyzed sepa-
rately. PITP does not function as a co-factor for these
enzymes in this system. Because the effects of PITP are
nonstoichiometric and not immediate, we conclude that
PLC and the lipid kinases studied in these experiments
use bilayer lipids rather than protein-bound lipids as sub-
strates. Thus, increased polyphosphoinositides are mostly
associated with cellular membranes and not with the
PITP, which does not stably associate with membranes in
turkey erythrocyte ghosts. Consistent with this suggestion
is the failure to observe the binding of PITP to plasma
membranes by immunocytochemical studies [29].
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Table 1
The effect of PITP on PI mass in turkey erythrocyte ghosts.
PITP [3H]-PI (d.p.m.) PI mass (nmol phosphate)
– 29 030 310 9.8 
+ 12 729 880 6.4 
Percentage change 44% 65%
in PI content
Difference 3.4
[3H]-inositol-labelled turkey erythrocyte ghosts were incubated with
5 mM ATP with or without approximately 1 nmol PITP for 2 h.
Phospholipids were then extracted and separated on silica-60 HPTLC
plates using chloroform:ethanol:water:triethylamine (4:5:1:4 v/v/v/v).
The PI band was identified by reference to an authentic standard
(Sigma) and extracted from the silica. The PI was then separated from
contaminating phospholipids by HPTLC in the same solvent system
using borate-impregnated plates. PI was extracted from the silica as
before and then refluxed in PCA for 3 h at 230°C. PI mass was then
determined by phosphate assay [26].
Figure 2
The continued presence of PITP is not required for the enhancement of
inositol phosphate production. Well-washed ghosts labelled with [3H]-
inositol in PI were labelled for 2 h with 10 mM ATP in the presence or
absence of PITP, as indicated. Ghosts were then washed four times in
20 volumes of lysis buffer and then the PLC was stimulated for 4 min in
the presence or absence of PITP before being processed for inositol
phosphate and lipid analysis, as described in the Materials and methods
section. Points show mean ± standard deviation (n = 3) from a single
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The effects of PITP in turkey erythrocytes can be
explained by the lipid supply model as originally proposed
by Michell [19]. The levels of polyphosphoinositides in
cells are maintained at steady state by two substrate cycles
([13]; Fig. 3). In turkey erythrocyte ghosts, these substrate
cycles are disrupted because the ghosts are depleted of
their polyphosphoinositide phosphatases relative to the
opposing kinases (data not shown), and therefore any
polyphosphoinositides that are formed by incubation of
ghosts with ATP will be effectively trapped. This would
be expected to deplete the plasma membrane of PI in the
vicinity of the PI 4-kinase and so create a gradient of PI
between this site and other membranes that do not
contain a PI 4-kinase. As the kinetic parameters of PITP
are such that it should act to maintain the typically
observed ratio of PI:phosphatidylcholine in cell mem-
branes [30], anything that caused a localized depletion of
PI could obviously be the driving force for the net transfer
of PI and could provide the basis for the reconstituting
abilities of PITP. In an intact cell, this model predicts that
steady-state levels of polyphosphoinositides would be
maintained until the activation of PLC, which would
divert PIP2 out of the substrate cycles. PIP2 would be
maintained at the expense of PI in the vicinity of the
phosphoinositide kinases, creating a gradient of PI which
the presence of a PITP would tend to correct. If this
model is correct, it would explain the need for the sub-
strate cycles, as without the phosphatases, even a small
amount of phosphoinositide kinase activity would eventu-
ally lead to all the PI in a cell being converted into
polyphosphoinositides.
The reason for the differences between the mechanism of
PITP action in turkey erythrocyte ghosts and the mecha-
nism that was proposed for PITP in HL-60 cells perme-
abilized with streptolysin O is not readily apparent, but
might result from differences in the protocols used. In the
experiments described here, ghosts were preincubated
with PITP; in the experiments of Cunningham et al. [20],
however, the PITP was added at the same time as the
GTPgS and the subsequent enhancement of inositol
phosphate production occurred after a short lag period,
which would deplete PI in the vicinity of the phospho-
inositide kinases/PLC, therefore creating a driving force
for the transfer of PI by the transfer protein. Moreover, the
earliest time points described in the experiments of Cun-
ningham et al. [20] began approximately 2 minutes after
stimulation, whereas the initial rates of PI 4-kinase activity
were readily measurable within the first minute after ATP
addition to turkey erythrocyte ghosts. 
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Figure 3







































Model for the action of PITP. Under basal, unstimulated conditions, the
steady-state levels of the polyphosphoinositides are maintained by the
two substrate cycles between PI and PIP2. PITP, by acting to
equilibrate the PI:phosphatidylcholine ratio between the cytoplasmic
leaflets of intracellular membranes, can be considered as catalyzing an
additional ‘substrate cycle’ in the synthesis of PIP2. Upon stimulation of
PLC, polyphosphoinositides are diverted out of the
kinase/phosphatase substrate cycles causing a local depletion of PI in
the plasma membrane. The PITP will then catalyze a net transfer of PI
to the plasma membrane from other membranes. Erythrocyte ghosts,
which have lost their polyphosphoinositide phosphatase activities
relative to the kinases, are in effect in a ‘pseudo-activated’ state, in
which any PI which is transferred will be phosphorylated and then
trapped as polyphosphoinositides. This means that there will always be
a driving force for further supply of PI into the plasma membrane.
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The rates measured by Cunningham et al. [20] may there-
fore not be reliable estimates of the true initial rates of
phosphoinositide kinases or PLC. Given the extensive
homologies between the components that regulate PLCbs
in turkey erythrocytes and in mammalian systems, it seems
unlikely that our failure to observe a co-factor-like activity
is due to some cell-type-specific mechanism. Also, as both
mammalian PITPs and the structurally unrelated Saccha-
romyces cerevisiae PITP, Sec14p, can all reconstitute equally
well in permeabilized HL-60 cells when matched for PI
transfer activity [28], it seems more likely that it is the PI
transfer activity, rather than any specific co-factor function,
which is the critical component in this action of PITP.
Our recent results [31] suggest that PLCb and inositol
lipid kinases form a coupled enzyme system, the structural
relationships of which are maintained by association with
the actin cytoskeleton. We propose that PITP fuels this
system by supplying PI down a chemical concentration
gradient between membranes. Although PITP does not
directly stimulate the relevant lipid kinases or PLC, our
results do not rule out the possibility that PITP might be
targeted to sites of signalling by reversible association with
a suitable docking protein. The PI 4-kinase itself would
be a good candidate for such a docking protein as PI could
then be channelled to its sites of phosphorylation. This
idea may explain the finding that PITP is associated in a
signalling complex with both the epidermal growth factor
receptor and a PI 4-kinase activity [16]. Nevertheless, it
now seems likely that the lipid kinases themselves use
membrane-bound, rather than PITP-bound, substrates.
Conclusions
We have investigated the effect of PITP on phosphoinosi-
tide metabolism in turkey erythrocyte ghosts. In this
system, PITP functions solely as a lipid transfer protein
without any discernible co-factor activity. In our model,
the transfer protein catalyzes the continuous transfer of PI
between biological membranes. Under unstimulated con-
ditions in intact cells, polyphosphoinositide levels are
maintained at steady-state and there is no net transfer of
PI between membranes. Any biochemical change that dis-
rupts the steady-state levels, such as activation of a PLC,
would cause a depletion of polyphosphoinositides, which
in turn would create a PI gradient, thereby allowing net
transfer of PI into the depleted membrane. In permeabi-
lized cells, the substrate cycles may be disrupted by the
loss of polyphosphoinositide phosphatases, which would




PITP was purified from bovine brains by a method similar to that
described by Helmkamp et al. [25]. The protein was purified 260-fold
from the 100 000 × g supernatant of a bovine brain homogenate by
ammonium sulphate fractionation followed by dialysis and sequential
chromatography on fast flow Q–sepharose, Bio-Gel HPT–hydroxy-
apatite and Sephadex G-100 gel filtration.
Assay of PITP activity
PITP activity was assayed in 200 ml 10 mM HEPES (pH 7.0), 10 mM
MgCl2 using 1 mg ml–1 [3H]-inositol-labelled ghosts as donor mem-
branes and 1 mg ml–1 phosphatidylcholine:PI vesicles (49:1 w/w) as
acceptor vesicles. Reactions were initiated by addition of 50ml of
column fractions to 200 ml of the ghost/vesicle mix, incubated for 30 min
at 37°C and terminated by centrifugation for 30 sec at 13 000 r.p.m. in 
a microfuge followed by quenching 125ml supernatant in 750 ml
CHCl3:MeOH:conc. HCl (40:80:1 v/v/v). A phase split was achieved by
addition of 250 ml CHCl3 and 350 ml 0.1 M HCl followed by vortexing
and centrifugation as above. An aliquot of the lower phase was mixed
with Opti-Phase and radioactivity determined by scintillation counting.
Labelling of turkey erythrocyte ghosts and assays of
phosphoinositide kinase and PLC
Well-washed turkey erythrocyte ghosts were prepared as described
[27]. Labelling of the phosphoinositides in well-washed ghosts with [3H]-
inositol and subsequent PLC assays were performed as described [27]
with 5 mM ATP and 100 mM GTPgS as agonist. Phosphoinositide kinase
assays were essentially identical to the PLC assays except that the
ghosts were labelled with [3H]-inositol only in PI and incubated with ATP
in the absence of GTPgS. Labelled ghosts were pre-incubated with PITP
for 5 min at 37°C before initiation of the reactions. Reactions were termi-
nated with equal volumes of 1 M trichloroacetic acid (TCA) and samples
processed for inositol phosphates and lipids as described [32].
Measurement of PI mass
Ghosts (3 mg protein) labelled with [3H]-inositol were incubated with or
without 1 nmol PITP for 2 h at 37°C in 3 ml intracellular buffer containing
an ATP-regenerating system as described above. Reactions were termi-
nated by addition of an equal volume of 1 M TCA. The precipitate was
collected by centrifugation and extracted with 1.5 ml CHCl3:MeOH:
conc. HCl (40:80:1 v/v/v). A phase split was achieved by addition of 0.5
ml CHCl3 and 0.9 ml 0.1 M HCl followed by vortex mixing and centrifuga-
tion. The lower phase was removed, dried in vacuo, resuspended in
CHCl3:MeOH (2:1 v/v) and loaded onto a silica-60 HPTLC plate (Merck)
in a 2 cm streak. Lipids were resolved in CHCl3:EtOH:H2O:triethylamine
(4:5:1:4 v/v/v/v) and visualized by iodine staining. The band correspond-
ing to PI, as determined by co-migration with an authentic lipid standard
(Sigma), was cut out, the lipid was eluted from the silica, dried down and
re-chromatographed on borate-impregnated silica-60 HPTLC plate. PI
was resolved in the same solvent system and re-extracted. The purified PI
was then refluxed in perchloric acid at 240°C for 3 h and PI mass was
determined by phosphate assay [26]. Recovery of PI was assessed by
the recovery of [3H]-label in the phosphate assay compared to the
amount of [3H]-PI present in an aliquot of the original sample. Recovery
ranged between 30% and 50%.
Materials
All chemicals were from Fisons, BDH or Boehringer and were AnalaR
grade or higher. Bovine brains were from Advanced Protein Products
Ltd. Fast flow Q–sepharose was from Pharmacia, Bio-Gel HTP from Bio-
Rad and Sephadex G-100 from Sigma. [3H]-Inositol was from NEN. Anti-
PITP antiserum was a gift from S. Cockcroft.
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